Holdaway IM, Rajasoorya C 1999 Epidemiology of acromegaly. Pituitary 2:29-41
Bihan H, Espinosa C, Valdes-Socin H, Salenave S, Young J, Levasseur S, Assayag P, Beckers A, Chanson P 2004 Long-term outcome of patients with acromegaly and congestive heart failure. J Clin Endocrinol Metab 89:5308-5313
Delhougne B, Deneux C, Abs R, Chanson P, Fierens H, Laurent-Puig P, Duysburgh I, Stevenaert A, Tabarin A, Delwaide J, Schaison G, Belaiche J, Beckers A 1995 The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. J Clin Endocrinol Metab 80:3223-3226
Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, Koukoulis G 2008 Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J Gastroenterol 14:3484-3489
Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP 2008 Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93:61-67
van der Lely AJ, Beckers A, Daly AF, Lamberts SWJ, Clemmons DR 2005 Acromegaly: pathology, diagnosis, and treatment. Boca Raton, FL: Taylor & Francis
Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JA 1999 Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 50:561-567
Freda PU, Katznelson L, van der Lely AJ, Reyes CM, Zhao SH, Rabinowitz D 2005 Long-acting somatostatin analog therapy of acromegaly: a meta- analysis. J Clin Endocrinol Metab 90:4465-4473
Melmed S, Sternberg R, Cook D, Klibanski A, Chanson P, Bonert V, Vance ML, Rhew D, Kleinberg D, Barkan A 2005 A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly. J Clin Endocrinol Metab 90:4405-4410
Bevan JS 2005 Clinical review: the antitumoral effects of somatostatin analog therapy in acromegaly. J Clin Endocrinol Metab 90:1856-1863
Ezzat S, Horvath E, Harris AG, Kovacs K 1994 Morphological effects of octreotide on growth hormone-producing pituitary adenomas. J Clin Endocrinol Metab 79:113-118
Beckers A, Kovacs K, Horvath E, Abs R, Reznik M, Stevenaert A 1991 Effect of treatment with octreotide on the morphology of growth hormone-secreting pituitary adenomas: study of 24 cases. Endocr Pathol 2:123-131
Barkan AL, Lloyd RV, Chandler WF, Hatfield MK, Gebarski SS, Kelch RP, Beitins IZ 1988 Preoperative treatment of acromegaly with long-acting somatostatin analog SMS 201-995: shrinkage of invasive pituitary macroadenomas and improved surgical remission rate. J Clin Endocrinol Metab 67:1040-1048
Stevenaert A, Beckers A, Kovacs K, Bastings E, De Longueville M, Hennen G 1988 Experience with Sandostatin in various groups of acromegalic patients. In: Lamberts SWJ, ed. Sandostatin in the treatment of acromegaly: consensus round table, Amsterdam, 1987. Berlin: Springer Verlag; 95-101
Stevenaert A, Beckers A 1992 Presurgical octreotide treatment in acromegaly. Metabolism 41(Suppl 2):51-58
Losa M, Ciccarelli E, Mortini P, Barzaghi R, Gaia D, Faccani G, Papotti M, Mangili F, Terreni MR, Camanni F, Giovanelli M 2001 Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas. J Clin Endocrinol Metab 86:5194-5200
Colao A, Ferone D, Cappabianca P, del Basso De Caro ML, Marzullo P, Monticelli A, Alfieri A, Merola B, Calì A, de Divitiis E, Lombardi G 1997 Effect of octreotide pretreatment on surgical outcome in acromegaly. J Clin Endocrinol Metab 82:3308-3314
Biermasz NR, van Dulken H, Roelfsema E 1999 Direct postoperative and follow-up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared to those in untreated matched controls. J Clin Endocrinol Metab 84:3551-3555
Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen O, Svartberg J, Cooper JG, Hald JK, Fougner SL, Bollerslev J, on behalf of the POTA study group 2008 Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomized trial. J Clin Endocrinol Metab 93:2984-2990
